Skip to main content
Equibles
ANAB $56.96 +3.04%
ANAB logo
ANAB · Anaptysbio, Inc
Track ANAB — free

Use ANAB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$56.96 +1.68 (+3.04%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.66B
Shares
29.10M
All earnings calls

Earnings call · FY2026 Q1

Anaptysbio, Inc (ANAB) Q1 2026 Earnings Call

Concluded May 12, 2026
May 12, 2026 0 turns
Period
FY2026 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $25.56M -8% YoY
Diluted EPS -$1.84
Net income -$52.88M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 12, 2026 10-Q report Filed May 12, 2026

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Royalty Management Company$25.56M -8% YoY
Biopharma Company$0
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)